Authors: Mueller TF, Mas VR
Abstract
The increase in progressive kidney disease, rising numbers of patients with end-stage renal disease, organ shortages for kidney transplants and poor long-term graft survival rates underline the need for better strategies to diagnose, prevent and treat renal disease. Histological analysis, based on renal biopsies and readings of morphology, has limitations as key information for the management of the individual patient, and complementary technologies are needed. The sequencing of the human genome has provided the platform for applied molecular phenotyping. Microarray technology has become a routine method for robust high-throughput measurements of genome-wide transcriptome levels. This review will give examples of transcriptome profiling in nephr...